4F-MDMB-BINACA Wikipedia - Versionsgeschichte

ScarlettCagle66 am 4. Juni 2026 um 08:55 Uhr

2026-06-04T08:55:10Z

ScarlettCagle66 am 4. Juni 2026 um 08:54 Uhr

2026-06-04T08:54:34Z

ScarlettCagle66 am 4. Juni 2026 um 08:48 Uhr

2026-06-04T08:48:28Z

CaroleHoller04 am 1. Juni 2026 um 17:21 Uhr

2026-06-01T17:21:36Z

ScarlettCagle66 am 1. Juni 2026 um 17:15 Uhr

2026-06-01T17:15:42Z

FranchescaWorth am 30. Mai 2026 um 18:49 Uhr

2026-05-30T18:49:05Z

ScarlettCagle66 am 30. Mai 2026 um 18:33 Uhr

2026-05-30T18:33:56Z

ScarlettCagle66 am 30. Mai 2026 um 18:33 Uhr

2026-05-30T18:33:39Z

StefanCalvin9 am 26. Mai 2026 um 22:09 Uhr

2026-05-26T22:09:28Z

StefanCalvin9: Die Seite wurde neu angelegt: „Synthetic cannabinoids have consistently been shown to produce discriminative stimulus effects similar to those [https://cannabinoidsrc4f-adb.com/ 5CLADBA] of…“

2026-05-26T22:00:24Z

Die Seite wurde neu angelegt: „Synthetic cannabinoids have consistently been shown to produce discriminative stimulus effects similar to those [https://cannabinoidsrc4f-adb.com/ 5CLADBA] of…“

Neue Seite

Synthetic cannabinoids have consistently been shown to produce discriminative stimulus effects similar to those [https://cannabinoidsrc4f-adb.com/ 5CLADBA] of Δ9-THC (Bannister and Connor, 2018), and MDMB-FUBINACA fully substituted for Δ9-THC (Gamage et al., 2018). The chemical structures of the recent synthetic cannabinoids are unlike that of Δ9-THC, but are largely based on the structure of older synthetic cannabinoids that are known to have substantial abuse liability (Fig. 1). All 5 compounds decreased locomotor activity and produced discriminative stimulus effects similar to those of Δ9-THC, which suggests they may have abuse liability similar to that of Δ9-THC. Subsequent testing identified 5F-ADB to have been present in a total of ten people who had died from unexplained drug overdoses in Japan between September 2014 and December 2014. AMB-FUBINACA produced tremors and may be of increased risk in human recreational users. Michael B Gatch Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/kg. Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the highest dose tested (0.5 mg/kg). Figure 1 shows average horizontal activity counts/10 min as a function of time (0–4 h) and dose of Δ9-TH Figure 1. Each training session lasted a maximum of 10 min, and the rats could earn up to 20 food pellets. Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden 5CLADBA headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly availabl Figure 1. These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit Taken together these data further confirmed the structure elucidation of B16. The precursor ion m/z 276 (B1) detected, which was 74 Da lower than that for the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicated N-dealkylation of B22. The precursor ion m/z 348 and product ion detected at m/z 217 (B2) identified was 2 Da less than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicating oxidative defluorination (loss of fluorine with addition of hydroxy 5CLADBA group Buy Jwh-210 at USA K2 INCENSE STORE and enjoy premium quality, flexible quantities, and fast, secure shipping. Fast shipping and pure product-highly recommended for anyone needing quality incense ingredients." 🌟🌟🌟🌟🌟 You can buy jwh-210 online in quantities of 5CLADBA 10g, 30g, 50g, 100g, 150g, and 200g at USA K2 INCENSE STORE for premium quality and discreet shipping. In some areas, it is classified as a controlled substance, while in others, it may be legal for research or incense use. The legal status of jwh-210 varies by country and region. Key Features and Specifications to Evaluate In case of cannabis or Δ9-tetrahydrocannabinol, there are many 5CLADBA previous studies regarding with their dependence potential and neurotoxicity (Cororan, et al., 1974; Harris, et al., 1974; Leite and Culini, 1974; Hutcheson, et al., 1998). After administering test substances once every other day for 10 days, brain samples of mice were collected, especially at nucleus accumbens and hippocampus regions. Drug was administered 5 times every other day, and the first trial was performed 2 h after the last administration. How to Choose Powder JWH-210 This dual-use nature underscores the importance of responsible sourcing and strict adherence to legal frameworks. Forensic labs, public health researchers, and customs officials use authentic samples like JWH-210 to distinguish between legal and illegal compounds in seized materials. For those seeking a dependable compound for analytical purposes, JWH-210 Chemical Powder provides a trusted and effective solution. With its carefully controlled production process, stable composition, and secure packaging, it remains a valuable resource for laboratory-based research. Is JWH-210 Legal? To evaluate whether the changes of coordinative functions by CNS damages were due to test substances, rota-rod test was performed using Rota-rod apparatus (Daejong, Seoul, Korea). The test apparatus for the locomotor activity test was designed to measure locomotor activity automatically using UV system (AM 1051, Benwick Electronics, Benwick, UK) when experimental animals moved in the chamber. In both tests, a group of mice were treated with negative control (vehicle, 1 mg/kg, i.p.), positive control (methamphetamine, 1 mg/kg, i.p.), or one of the three doses of test substances (0.1, 1, 5 mg/kg, i.p.) once every other day for 10 day

← Nächstältere Version		Version vom 4. Juni 2026, 08:55 Uhr
Zeile 1:		Zeile 1:
−	LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden ~~4F ADB~~ headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly availabl<br><br><br>~~Synthetic cannabinoids have consistently been shown to produce discriminative stimulus effects similar to those [https://cannabinoidsrc4f~~-~~adb.com/ 4F ADB] of Δ9~~-~~THC (Bannister~~ and ~~Connor, 2018),~~ and ~~MDMB~~-~~FUBINACA fully substituted~~ for ~~Δ9-THC (Gamage et al.~~, ~~2018). The chemical structures~~ of ~~the recent synthetic cannabinoids are unlike that of Δ9-THC~~, ~~but are largely based on~~ the ~~structure of older synthetic cannabinoids that are known~~ to ~~have substantial abuse liability (Fig. 1). All 5 compounds decreased locomotor activity~~ and ~~produced discriminative stimulus effects similar to those of Δ9-THC~~, ~~which suggests they may have abuse liability similar to that~~ of Δ9-~~THC. Subsequent testing identified 5F-ADB to have been present in~~ a ~~total of ten people who had died from unexplained drug overdoses in Japan between September 2014 and December 2014~~. ~~AMB~~-~~FUBINACA produced tremors and may be of increased risk in human recreational~~ users.~~<br>Michael B Gatch <br>Duration~~ of ~~the locomotor depression increased over dose from 30 min following 0~~.~~1 mg/kg to 2~~.~~5 h following 1 mg/kg. Substantial depressant effects were observed within the first 10 min~~, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and ~~maximal depression was observed between 10–40 min and lasted up~~ to ~~2.5 to 3 h at~~ the ~~highest dose tested~~ (~~0.5 mg/kg~~). ~~Figure 1 shows average horizontal activity counts/10 min as a function of time (0–4 h) and dose of Δ9-TH~~<br><br><br>~~To evaluate whether the changes~~ of ~~coordinative functions by CNS damages were due~~ to ~~test~~ substances, ~~rota-rod test was performed using Rota-rod apparatus (Daejong, Seoul~~, ~~Korea). The test apparatus for the locomotor activity test was designed to measure locomotor activity automatically using UV system (AM 1051~~, ~~Benwick Electronics~~, ~~Benwick~~, ~~UK) when experimental animals moved in the chamber~~. ~~In both tests~~, ~~a group of mice were treated with negative control (vehicle~~, ~~1 mg/kg~~, ~~i.p.~~), ~~positive control~~ (~~methamphetamine, 1 mg/kg, i.p.~~)~~, or one of~~ the ~~three doses~~ of ~~test substances (0.1~~, ~~1, 5 mg/kg, i~~.~~p.) once every other day for 10 day<br><br><br>The same procedure~~ was ~~then applied~~ to ~~the mice once every day for 5 days. It was considered as coordination disturbance when mice fell from the test apparatus within 2 min. Mice~~ that ~~remained their position on~~ the ~~running apparatus~~ at ~~10 rpm for at least 2 min were selected for further evaluation.<br>Table of Conten<br><br>It is not known whether~~ the ~~increased toxicity is~~ due ~~only~~ to ~~activation of CB1 cannabinoid receptors more strongly than Δ9-THC or whether these "super-strength" cannabinoids produce effects at other receptor~~<br><br>~~In-vitro metabolism studies are generally used to complement these data using perfused organs~~, ~~tissue or cell cultures and microsomal preparations amongst which pooled human liver microsomes (HLM) have been frequently used to elucidate metabolism~~ of ~~SCBs [12,13,14,15,16<br><br> Figure 1. <br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9~~-~~THC) found~~ in ~~marijuana~~, ~~but have different chemical structures unrelated to Δ9~~-~~THC, different metabolism,~~ and ~~often greater toxicity (Fantegrossi et al~~.~~, 2014)~~. ~~Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol~~ (~~3 mg/kg~~, ~~30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB~~, ~~5F-ADB-PINACA)~~, ~~MDMB-CHIMICA~~, ~~MDMB-FUBINACA~~, ~~ADB-FUBINACA~~, ~~and AMB-FUBINACA (also known as FUB-AMB~~, ~~MMB-FUBINACA~~) were ~~tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con~~. ~~All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in~~ a ~~dose-dependent manner. A total~~ of ~~5 mice in~~ the ~~JWH~~-~~081 (5 mg/kg, i~~.~~p.) treated group and 6 mice~~ in the ~~4F ADB JWH-210 (5 mg/kg, i.p.) treated group showed loss~~ of ~~traction, of which 4 and 5 showed tremor, respectively. Memory retention was measured after~~ the ~~memory acquisition was tested as a probe trial~~.<br> About Powder JWH-2<br><br> The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in human	+	The locomotor activity assay was used to identify approximate time courses and dose ranges of psychoactive effects, which is useful for identifying parameters for drug discrimination experiments and are also predictive of the time course of the psychoactive effects in human user<br><br><br>In the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and water-maze test for learning/memory evaluation. Known for its stability and consistent composition, this compound is frequently utilized by professionals seeking reliable materials for laboratory-based analytical studies. In this study, histopathological evaluation was performed to confirm the possibility of neurotoxicity of the tested substances by hematoxylin and eosin staining method from collected brain samples. In the present study, we evaluated the neurotoxicity of two synthetic cannabinoids (JWH-081 and JWH-210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses (0.1, 1, 5 mg/kg). Selecting powder JWH-210 demands careful evaluation of purity, legality, and supplier credibility. Prices for research-grade JWH-210 vary significantly based on quantity, purity, and vendor complianc<br><br><br>As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-cigarette) earlier that day just before the onset of his symptoms. Metabolic acidosis (1/3, 0/7) and respiratory acidosis (1/3, 0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance detected, while in seven other substances of misuse were also detected including other SCRA, opioids, benzodiazepines cocaine and pregabali<br><br><br>LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden [https://cannabinoidsrc4f-adb.com/ adb butinaca] headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly availabl<br><br><br>LC separates the urine or blood sample and QTOF-MS provides high-resolution and accurate mass measurements for precise identification and structural elucidation of compounds. The LC-QTOF-MS method offers a more comprehensive and sensitive approach for drug detection, covering hundreds of recreational drugs, including NPS. Besides increasing the temperature to enlarge the drug aerolisation and bioavailability, one can elevate the flow rate of air through the e-cigarette and/or add a diluent . Of all e-cigarette users registered at this forum, 7.8 % vaped SCRAs . About 15 % of individuals registered at forums for drug users such as erowid.org who vaped cannabis have also vaped SRCAs. SCRAs belong, together with synthetic opioids, cathinones, amphetamines and hallucinogens to the new psychoactive substances (NPS) that are currently developed at high speed.<br>Data availabili<br><br><br>A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours .<br>Data availability <br>Moreover, a study conducted in the United Kingdom investigated components of e-liquids in 112 samples originating from prisoners, teenagers and test purchases of commercially available e-cigarettes taken between 2014 and 2021 . This is the first case report that describes the toxicological symptoms of vaping ADB-BUTINACA. Results of the DOA test (including testing for amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opioids, cannabis, tricyclic antidepressants) were available within 30 minutes and were all negative. We report a case of an involuntary intoxication of the SCRA ADB-BUTINACA after vaping. There are several pitfalls in the detection of SCRA in samples taken from the patient.<br>Data availabili

← Nächstältere Version		Version vom 4. Juni 2026, 08:54 Uhr
Zeile 1:		Zeile 1:
−	~~Similarly~~, ~~precursor ion identified at m/z 380 (B19/B21~~, ~~B23/B25) was 16 Da higher than~~ the 4F-~~MDMB~~-~~BINACA~~, ~~indicating monohydroxylation at~~ the ~~butyl side chain~~ (~~B19/B21~~) and ~~indazole (B23~~/~~B25) moieties with product ions m~~/~~z 145 and 161, respectively~~. ~~Metabolites identified at m~~/~~z 366~~ (B8, ~~B9, B13~~), ~~which was 16 Da higher than the 4F~~-~~MDMB~~-~~BINACA ester hydrolysis metabolite~~ (~~B22~~), ~~confirmed monohydroxylation upon ester hydrolysis~~. ~~Death involving these drugs have been reported [~~5~~,6,7,8,9],~~ and ~~this raises public health and social concerns. Due~~ to ~~their~~ similar ~~physiological effects~~ to ~~the principal psychoactive component~~ of ~~cannabis,~~ Δ9-~~tetrahydrocannabinol (~~THC~~), SCBs are gaining popularity~~ and ~~are often abused as recreational drugs~~. ~~The fact that similar 4F~~-~~MDMB-BINACA~~ and ~~ethanol concentrations were detected in the postmortem blood samples~~ of ~~both victims suggests that both substances played a role~~ in ~~the fatal outcom~~<br><br>~~In general,~~ the locomotor depressant ~~and discriminative stimulus~~ effects ~~have been~~ observed ~~at doses that do not produce adverse effects~~, ~~although tremors~~ were observed ~~upon handling~~ in mice ~~that received JWH-210~~ (~~Gatch et al~~.~~, 2016)~~, and ~~5F-AMB produced sustained vocalization~~ and ~~convulsions in rats~~ (~~Gatch et al~~.~~, 2018~~<br><br><br>~~Test 2 was performed everyday for 5 days after consecutive administration~~ of ~~the~~ substances, ~~including negative~~ (~~vehicle~~) ~~and positive (methamphetamine) controls~~. ~~After~~ the ~~last administration, the first trial was performed. Morris water maze~~ test was ~~performed~~ to ~~evaluate the changes of learning and memory function through administration of~~ the ~~test substances~~. ~~Generally~~, ~~neurotoxicity~~ of ~~a substance is evaluated by animal behavioral aspects~~, i.e. ~~functional observation battery (FOB~~) ~~tests~~ (~~O’Callaghan et al.~~, ~~2014)~~. ~~Our results suggest that JWH-081 and JWH-210 may [https://cannabinoidsrc4f-adb~~.~~com/ 5CLADBA] be neurotoxic substances through changing neuronal cell damages~~, ~~especially in~~ the ~~core shell part~~ of ~~nucleus accumbens~~.<br>~~About Powder JWH-2~~<br><br>~~<br>Locomotor activity in mice~~ was ~~tested~~ to ~~screen~~ for ~~locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect~~. ~~Previous studies have demonstrated~~ that ~~these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act~~ at ~~the CB1 receptor. Tremors~~ were ~~not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0~~.~~1 mg/kg, which~~ is 10-fold lower than the dose that produced tremors in the mice. AMB-FUBINACA has been implicated in severe adverse effects in recreational users (Adams et al., 2017; Hamilton et al., 2017), which suggests that the ~~range between behaviorally active and toxic doses of AMB-FUBINACA~~ is ~~narrow. Following that line~~ of ~~reasoning, it should also be noted that some of the~~ more ~~recent compounds produced non~~-~~linear dose~~-~~effect curves and one compound produced an inverted U~~-~~shaped dose-effect~~, ~~such that intermediate dose fully substituted, but higher doses did not~~ (~~Gatch and Forster, 2018~~)~~. All~~ of the compounds identified as available on the recreational market and submitted to our laboratory by the US Drug Enforcement Agency for testing have fully substituted at some dose (Gatch and Forster 2014, ~~2015~~, ~~2016~~, ~~2018); however; it is important to note that not all structural congeners are active (Wiley et al.~~, ~~2012~~<br><br><br>~~LC separates the urine or blood sample~~ and ~~QTOF~~-~~MS provides high~~-~~resolution~~ and ~~accurate mass measurements for precise identification and structural elucidation of compounds~~. ~~The LC-QTOF-MS method offers a more comprehensive and sensitive approach for drug detection~~, ~~covering hundreds of recreational drugs, including NPS~~. ~~Besides increasing the temperature~~ to ~~enlarge the drug aerolisation and bioavailability~~, ~~one can elevate the flow rate of air through the e~~-~~cigarette and/or add a diluent~~ . ~~Of all e~~-~~cigarette users registered at this forum~~, ~~7.8 % vaped SCRAs . About 15 % of individuals registered at forums for drug users such as erowid.org who vaped cannabis have also vaped SRCAs. SCRAs belong~~, ~~together with synthetic opioids~~, ~~cathinones~~, ~~amphetamines~~ and ~~hallucinogens to the new psychoactive substances~~ (~~NPS~~) ~~that are currently developed at high speed.~~<br>~~Data availabili~~<br><br>~~<br>High resolution mass spectrometry such as LC-QTOF~~-~~MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances~~. A ~~point-~~of-~~care drugs of abuse~~ (~~DOA~~) ~~test was initially performed on~~ the ~~urine~~ of ~~the patient. He confirmed drinking 750 ml energy drink without any further consumption~~ of ~~food~~ and ~~using an e-cigarette from Gaziantep~~, ~~Turkey 10 seconds before~~ the ~~onset of his first symptoms. He usually smokes~~ a ~~pack of cigarettes a day and sometimes smokes e-cigarettes~~. ~~Combined with non~~-~~specific, transient symptoms, clinical recognition of SCRA intoxication is challenging .~~<br>~~Data availability~~ <br>The ~~intensity is plotted against the retention time for both chromatograms~~, ~~demonstrating the 5CLADBA presence~~ and ~~elution profiles of nicotine and ADB~~-~~BUTINACA in~~ the ~~analysed vape liquid sample. LC-QTOF-MS Chromatograms of Nicotine (Top) and ADB-BUTINACA (Bottom) in the Vape Liquid used~~ by ~~the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine~~ and ~~ADB~~-~~BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able~~ to ~~detect synthetic recreational~~ drug ~~substances, the liquid of the e~~-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom	+	LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden 4F ADB headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly availabl<br><br><br>Synthetic cannabinoids have consistently been shown to produce discriminative stimulus effects similar to those [https://cannabinoidsrc4f-adb.com/ 4F ADB] of Δ9-THC (Bannister and Connor, 2018), and MDMB-FUBINACA fully substituted for Δ9-THC (Gamage et al., 2018). The chemical structures of the recent synthetic cannabinoids are unlike that of Δ9-THC, but are largely based on the structure of older synthetic cannabinoids that are known to have substantial abuse liability (Fig. 1). All 5 compounds decreased locomotor activity and produced discriminative stimulus effects similar to those of Δ9-THC, which suggests they may have abuse liability similar to that of Δ9-THC. Subsequent testing identified 5F-ADB to have been present in a total of ten people who had died from unexplained drug overdoses in Japan between September 2014 and December 2014. AMB-FUBINACA produced tremors and may be of increased risk in human recreational users.<br>Michael B Gatch <br>Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/kg. Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the highest dose tested (0.5 mg/kg). Figure 1 shows average horizontal activity counts/10 min as a function of time (0–4 h) and dose of Δ9-TH<br><br><br>To evaluate whether the changes of coordinative functions by CNS damages were due to test substances, rota-rod test was performed using Rota-rod apparatus (Daejong, Seoul, Korea). The test apparatus for the locomotor activity test was designed to measure locomotor activity automatically using UV system (AM 1051, Benwick Electronics, Benwick, UK) when experimental animals moved in the chamber. In both tests, a group of mice were treated with negative control (vehicle, 1 mg/kg, i.p.), positive control (methamphetamine, 1 mg/kg, i.p.), or one of the three doses of test substances (0.1, 1, 5 mg/kg, i.p.) once every other day for 10 day<br><br><br>The same procedure was then applied to the mice once every day for 5 days. It was considered as coordination disturbance when mice fell from the test apparatus within 2 min. Mice that remained their position on the running apparatus at 10 rpm for at least 2 min were selected for further evaluation.<br>Table of Conten<br><br>It is not known whether the increased toxicity is due only to activation of CB1 cannabinoid receptors more strongly than Δ9-THC or whether these "super-strength" cannabinoids produce effects at other receptor<br><br>In-vitro metabolism studies are generally used to complement these data using perfused organs, tissue or cell cultures and microsomal preparations amongst which pooled human liver microsomes (HLM) have been frequently used to elucidate metabolism of SCBs [12,13,14,15,16<br><br> Figure 1. <br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con. All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in a dose-dependent manner. A total of 5 mice in the JWH-081 (5 mg/kg, i.p.) treated group and 6 mice in the 4F ADB JWH-210 (5 mg/kg, i.p.) treated group showed loss of traction, of which 4 and 5 showed tremor, respectively. Memory retention was measured after the memory acquisition was tested as a probe trial.<br> About Powder JWH-2<br><br> The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in human

← Nächstältere Version		Version vom 4. Juni 2026, 08:48 Uhr
Zeile 1:		Zeile 1:
−	~~Thirty minutes prior to~~ the ~~training sessions, rats received an injection of either vehicle or Δ9~~-~~THC and were subsequently placed in the behavior~~-~~testing chambers~~, ~~where food~~ (~~45-mg food pellets; Bio-Serve, Frenchtown, NJ~~) ~~was available as a reinforcer for every ten responses~~ (~~FR10~~) ~~on a designated injection appropriate lever~~. ~~A houselight~~ was ~~centered over the hopper close to the ceiling and was illuminated only when~~ the ~~levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty~~-~~four male Sprague~~-~~Dawley rats were obtained from Envigo~~ (~~Houston~~, ~~TX)~~. [~~https://cannabinoidsrc4f-adb.com/ adb butinaca~~] ~~Male ND4 Swiss–Webster mice were obtained from Envigo (Houston~~, ~~TX) at approximately 8 weeks of age~~ and ~~maintained in~~ the ~~University~~ of ~~North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin<br><br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does~~ Δ9-tetrahydrocannabinol (~~Δ9-~~THC) ~~found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism~~, and often ~~greater toxicity (Fantegrossi et al~~.~~, 2014~~<br><br>~~It is~~ not ~~known whether the increased toxicity is due only to activation of CB1 cannabinoid receptors more strongly than Δ9-THC or whether these "super-strength" cannabinoids~~ produce effects ~~at other receptor<br><br>Legal status <br>~~JWH-210 ~~Chemical Powder offers a reliable solution for laboratories seeking a compound that meets stringent requirements~~. ~~Researchers often require compounds that are consistent and dependable~~, and ~~this product delivers on both fronts. Whether used in small~~-~~scale experiments or larger research projects, the compound maintains its integrity under recommended storage conditions. This ensures ease of handling~~ and ~~precise measurement during laboratory use~~. ~~Each batch undergoes detailed verification to ensure purity~~, consistency, and accuracy, making it suitable for controlled experimental environments. This study was supported by a grant (13181MFDS654) of the National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Kore<br><br>~~4. Drugs~~ <br>~~Short-onset~~, ~~short-acting compounds have a greater abuse liability~~, ~~and long-acting compounds pose problems~~ of ~~long-acting adverse effects~~ and ~~interactions with other drugs. The duration of action~~ of the ~~synthetic cannabinoids tested using the 8-h protocol have varied widely~~, ~~with some producing a duration~~ of ~~action no longer than 1 h, others producing~~ a ~~duration of action between 1–2 h~~, ~~and others lasting more than 2 h~~. ~~There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compounds~~. ~~All of the compounds tested in the present study depressed locomotor activity as is typical for other synthetic cannabinoids~~ (~~see review by Wiley~~ et al., ~~2017~~). ~~Average horizontal activity counts~~/~~10 min as a function of time (10 min bins) and dose~~. ~~Depressant effects~~ of ~~1.33 mg/kg were observed within 10 min following administration and peak depressant effects were observed between 0–30 min~~.<br>Michael B Gat<br><br>Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun<br><br><br>Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mice. AMB-FUBINACA has been implicated in severe adverse effects in recreational users (Adams et al., 2017; Hamilton et al., 2017), which suggests that the range between behaviorally active and toxic doses of AMB-FUBINACA is narrow. Following that line of reasoning, it should also be noted that some of the more recent compounds produced non-linear dose-effect curves and one compound produced an inverted U-shaped dose-effect, such that intermediate dose fully substituted, but higher doses did not (Gatch and Forster, 2018). All of the compounds identified as available on the recreational market and submitted to our laboratory by the US Drug Enforcement Agency for testing have fully substituted at some dose (Gatch and Forster 2014, 2015, 2016, 2018); however; it is important to note that not all structural congeners are active (Wiley et al., 2012<br><br><br>~~A limitation of this case report is that we did not have a~~ urine sample ~~available~~ for ~~additional NPS testing~~. ~~Point~~-of-~~care DOA tests using urine to screen~~ for ~~misuse~~ of ~~multiple substances~~, ~~regularly include cannabis~~, ~~amphetamines~~, ~~cocaine~~, opioids, ~~benzodiazepines~~ and ~~methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide~~ (~~LSD~~), ~~gamma~~-~~hydroxybutyrate~~ (~~GHB~~) and ~~ketamine are likely to become volatile under~~ the ~~temperature~~ of ~~current~~ e-cigarettes, ~~while crack cocaine~~ is ~~hard to vaporise~~. ~~A systematic review including data~~ of ~~114 patients~~ of ~~which~~ the ~~majority~~ was ~~intoxicated due to SCRA smoking revealed that 45 %~~ of the ~~patients who present~~ at the ER ~~after an intoxication due to SCRA smoking recovered within 24 hours~~	+	Similarly, precursor ion identified at m/z 380 (B19/B21, B23/B25) was 16 Da higher than the 4F-MDMB-BINACA, indicating monohydroxylation at the butyl side chain (B19/B21) and indazole (B23/B25) moieties with product ions m/z 145 and 161, respectively. Metabolites identified at m/z 366 (B8, B9, B13), which was 16 Da higher than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), confirmed monohydroxylation upon ester hydrolysis. Death involving these drugs have been reported [5,6,7,8,9], and this raises public health and social concerns. Due to their similar physiological effects to the principal psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC), SCBs are gaining popularity and are often abused as recreational drugs. The fact that similar 4F-MDMB-BINACA and ethanol concentrations were detected in the postmortem blood samples of both victims suggests that both substances played a role in the fatal outcom<br><br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018<br><br><br>Test 2 was performed everyday for 5 days after consecutive administration of the substances, including negative (vehicle) and positive (methamphetamine) controls. After the last administration, the first trial was performed. Morris water maze test was performed to evaluate the changes of learning and memory function through administration of the test substances. Generally, neurotoxicity of a substance is evaluated by animal behavioral aspects, i.e. functional observation battery (FOB) tests (O’Callaghan et al., 2014). Our results suggest that JWH-081 and JWH-210 may [https://cannabinoidsrc4f-adb.com/ 5CLADBA] be neurotoxic substances through changing neuronal cell damages, especially in the core shell part of nucleus accumbens.<br>About Powder JWH-2<br><br><br>Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mice. AMB-FUBINACA has been implicated in severe adverse effects in recreational users (Adams et al., 2017; Hamilton et al., 2017), which suggests that the range between behaviorally active and toxic doses of AMB-FUBINACA is narrow. Following that line of reasoning, it should also be noted that some of the more recent compounds produced non-linear dose-effect curves and one compound produced an inverted U-shaped dose-effect, such that intermediate dose fully substituted, but higher doses did not (Gatch and Forster, 2018). All of the compounds identified as available on the recreational market and submitted to our laboratory by the US Drug Enforcement Agency for testing have fully substituted at some dose (Gatch and Forster 2014, 2015, 2016, 2018); however; it is important to note that not all structural congeners are active (Wiley et al., 2012<br><br><br>LC separates the urine or blood sample and QTOF-MS provides high-resolution and accurate mass measurements for precise identification and structural elucidation of compounds. The LC-QTOF-MS method offers a more comprehensive and sensitive approach for drug detection, covering hundreds of recreational drugs, including NPS. Besides increasing the temperature to enlarge the drug aerolisation and bioavailability, one can elevate the flow rate of air through the e-cigarette and/or add a diluent . Of all e-cigarette users registered at this forum, 7.8 % vaped SCRAs . About 15 % of individuals registered at forums for drug users such as erowid.org who vaped cannabis have also vaped SRCAs. SCRAs belong, together with synthetic opioids, cathinones, amphetamines and hallucinogens to the new psychoactive substances (NPS) that are currently developed at high speed.<br>Data availabili<br><br><br>High resolution mass spectrometry such as LC-QTOF-MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep, Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack of cigarettes a day and sometimes smokes e-cigarettes. Combined with non-specific, transient symptoms, clinical recognition of SCRA intoxication is challenging .<br>Data availability <br>The intensity is plotted against the retention time for both chromatograms, demonstrating the 5CLADBA presence and elution profiles of nicotine and ADB-BUTINACA in the analysed vape liquid sample. LC-QTOF-MS Chromatograms of Nicotine (Top) and ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and ADB-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug substances, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom

← Nächstältere Version		Version vom 1. Juni 2026, 17:21 Uhr
Zeile 1:		Zeile 1:
−	~~Figure 1~~. <br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br>~~<br>The current study indicates that~~ the ~~test compounds produce locomotor depression similar~~ to ~~that~~ of Δ9-THC~~, and fully substitute for the discriminative stimulus effects of Δ9-THC. In summary,~~ these 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA have similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in a similar fashion. Much of the in vivo [https://cannabinoidsrc4f-adb.com/ navigate here] testing of the synthetic cannabinoid compounds have been pre-clinical studies focused on their cannabinoid-like effects ~~or like the present study, focused on their abuse liability. There is indication that at least some of the first-generation synthetic cannabinoids act~~ at ~~receptors~~ other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016<br><br><br>Due to the unknown toxicity of newly emerging SCRAs, forensic assessments of cases involving these substances are challenging. According to the reported cases and reviews of the scientific literature, concurrent ethanol consumption should amplify the toxicity of SCRAs. The concentration of 4F-~~MDMB-BINACA in the postmortem blood was 2~~.~~50 and 2.34 ng/mL, and blood alcohol concentration was 2.11~~ and ~~2.49 g/L~~, ~~respectively. Two fatal cases are reported caused by simultaneous consumption of 4F-MDMB-BINACA~~ and ethanol.<br>Fig. 2. <br>The precursor ion m/z 396 (B10, B12/B15) was 32 Da higher than the parent drug, 4F-MDMB-BINACA, suggesting the addition of two hydroxy groups. All the below explanations for transformations into metabolites are based on the data shown in Fig. Metabolites were identified according to their precursor ions, product ~~ions, and fragmentation patterns (Fig. 1). Traditional in-vivo metabolism studies to generate human metabolites of drugs relied heavily~~ on ~~the use of whole animal model systems, which are expensive, limited by drug administration amount, influenced by species variation and faced by many ethical issues~~. ~~Eight~~ in-~~vivo metabolites tentatively identified were mainly products of ester hydrolysis with~~ or ~~without additional dehydrogenation~~, N-dealkylation, monohydroxylation and oxidative defluorination with further oxidation to butanoic acid.<br>Fig. 1. <br>Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, navigate here liver microsomes and confirmed using urine samples The threshold for fatal overdose of combined use of SCRAs and ethanol can be estimated as a little ng/mL (0.37–4.1 ng/mL according to the ~~reported cases) of SCRA and 1~~.~~5–2.5 g/L~~ of ~~ethanol. The reported cases~~ and ~~reviews of the scientific literature suggest a possible synergistic effect between SCRAs and ethanol, because their combined~~ use ~~clearly increases their toxicity~~. ~~The victim died due~~ to severe necrotizing pancreatitis and acute kidney injury evolving into multi-organ failure 11 days after hospital admission . Studies have found no unequivocal synergistic effect between THC and ethanol at low or moderate ethanol doses [29, ~~30]~~, ~~but no data on high doses of ethanol are available. Given that THC~~ and ~~ethanol act on the same receptors~~, ~~data on their simultaneous use may yield important insights in this regard~~.~~<br>Fungus C. elegans <br>Concentrations~~ of ~~4F-MDMB-BINACA in~~ the ~~postmortem blood samples were 2.50~~ and ~~2.34 ng/mL~~, ~~which are in line with published data. Although the lethal dose~~ of ~~4F-MDMB-BINACA is unknown, its concentration in postmortem blood samples was found to range between 0.10~~ and ~~2.90 ng/mL . In SCRA-related cases in which the deceased suffered from heart disease~~, ~~the SCRA concentration in the postmortem blood was less than 1 ng/mL . Concentrations~~ of ~~SCRAs in postmortem cases cover a wide range ; however, some reports of survival have also been published—even at relatively high blood SCRA concentrations [19, 20~~<br><br> Furthermore, users of these vapes and alerting authorities may not notice the addition of recreational drugs to the e-liquid as the smell of recreational drugs is lost during vaping due to the specific smell of added flavours<br><br><br>Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound	+	Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). [https://cannabinoidsrc4f-adb.com/ adb butinaca] Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin<br><br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014<br><br>It is not known whether the increased toxicity is due only to activation of CB1 cannabinoid receptors more strongly than Δ9-THC or whether these "super-strength" cannabinoids produce effects at other receptor<br><br>Legal status <br>JWH-210 Chemical Powder offers a reliable solution for laboratories seeking a compound that meets stringent requirements. Researchers often require compounds that are consistent and dependable, and this product delivers on both fronts. Whether used in small-scale experiments or larger research projects, the compound maintains its integrity under recommended storage conditions. This ensures ease of handling and precise measurement during laboratory use. Each batch undergoes detailed verification to ensure purity, consistency, and accuracy, making it suitable for controlled experimental environments. This study was supported by a grant (13181MFDS654) of the National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Kore<br><br>4. Drugs <br>Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compounds. All of the compounds tested in the present study depressed locomotor activity as is typical for other synthetic cannabinoids (see review by Wiley et al., 2017). Average horizontal activity counts/10 min as a function of time (10 min bins) and dose. Depressant effects of 1.33 mg/kg were observed within 10 min following administration and peak depressant effects were observed between 0–30 min.<br>Michael B Gat<br><br>Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun<br><br><br>Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mice. AMB-FUBINACA has been implicated in severe adverse effects in recreational users (Adams et al., 2017; Hamilton et al., 2017), which suggests that the range between behaviorally active and toxic doses of AMB-FUBINACA is narrow. Following that line of reasoning, it should also be noted that some of the more recent compounds produced non-linear dose-effect curves and one compound produced an inverted U-shaped dose-effect, such that intermediate dose fully substituted, but higher doses did not (Gatch and Forster, 2018). All of the compounds identified as available on the recreational market and submitted to our laboratory by the US Drug Enforcement Agency for testing have fully substituted at some dose (Gatch and Forster 2014, 2015, 2016, 2018); however; it is important to note that not all structural congeners are active (Wiley et al., 2012<br><br><br>A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours

← Nächstältere Version		Version vom 1. Juni 2026, 17:15 Uhr
Zeile 1:		Zeile 1:
−	~~All of the compounds tested in the present study depressed locomotor activity as is typical for other~~ synthetic cannabinoids (~~see review by Wiley~~ et al., ~~2017~~). ~~Average horizontal activity counts~~/10 min as ~~a function of time~~ (~~10 min bins~~) ~~and dose. Depressant effects of 1.33 mg/kg~~ were ~~observed within 10 min following administration and peak depressant~~ effects ~~were 5CL ADBA powder observed between 0–30 min. Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg~~ to ~~2.5 h following 1 mg/k~~<br><br><br>~~LC-QTOF-MS represents a significant advancement in~~ the ~~field~~ of ~~drug detection, offering higher sensitivity, specificity~~, and ~~a broader spectrum of detectable substances. Despite all negative results in~~ the ~~point-~~of-~~care test for recreational drugs~~, ~~the liquid chromatography~~-~~quadrupole time~~-of-~~flight mass spectrometry (LC~~-~~QTOF~~-~~MS) analysis showed that the liquid of the e~~-~~cigarette contained ADB~~-~~BUTINACA,~~ a ~~synthetic cannabinoid~~. ~~We report a 27-year-old man who was admitted to~~ the ~~emergency room because of sudden~~ [https://cannabinoidsrc4f-adb.com/ ~~5CL ADBA powder~~] ~~headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly available.<br>Data availability <br>When~~ clinical ~~presentation and/~~or ~~initial DOA testing results are inconclusive~~, ~~additional testing with LC-QTOF-MS can be valuable and~~ is ~~recommended. SCRAs and other NPS may not be detected by point-~~of-~~care DOA tests~~. ~~In this case~~, the ~~point~~-of-~~care DOA urine screening~~ was not ~~able to detect the synthetic cannabinoid ADB-BUTINAC~~<br><br><br>~~Demographic and clinical features~~ are ~~recorded and blood and/or urine samples analysed using high-resolution accurate mass liquid chromatography-mass spectrometry~~. ~~The authors declare that they have no known competing financial interests or personal relationships that could have appeared~~ to ~~influence~~ the ~~work~~ reported ~~in this paper. Second~~, ~~we could not 5CL ADBA powder retrieve further detailed information about~~ the ~~e-cigarette that was used by the patient such as the label or the region~~ of ~~origin~~. ~~Whether a recreational drug can be administered via vaping, depends on whether the drug becomes volatile under the evaporation temperature~~ of the ~~e-cigarette~~. ~~Of these samples~~, ~~22 contained one or more SCRAs, THC~~ was ~~only detected in~~ 11 ~~samples, only one contained cannabidiol~~ and ~~6 contained a mixture of THC and cannabidiol~~. ~~There is difficulty in finding the right information about the NPS~~, ~~defining their potency and confirmation~~ of ~~their existence in e~~-~~liquids or urine samples~~.<br>~~Data availabili~~<br>~~<br><br>Locomotor activity in mice~~ was ~~tested to screen~~ for ~~locomotor depressant effects and~~ to ~~identify behaviorally-active dose ranges~~ and ~~times of peak effect~~. ~~Previous~~ studies ~~have demonstrated that these compounds have chemical structures similar~~ to ~~synthetic cannabinoids known to have substantial abuse liability~~ and ~~act at the CB1 receptor~~. ~~Tremors~~ were ~~not observed following AMB~~-~~FUBINACA during the drug discrimination study~~, ~~but the maximum dose tested was only 0~~.1 ~~mg/kg, which is 10~~-~~fold lower than the dose that produced tremors in the mice. AMB~~-~~FUBINACA has been implicated~~ in ~~severe adverse effects in recreational users~~ (~~Adams et al~~.~~, 2017; Hamilton et al~~.~~, 2017~~)~~, which suggests that the range between behaviorally active~~ and ~~toxic doses~~ of ~~AMB-FUBINACA is narrow~~. ~~Following that line of reasoning, it should also be noted that some~~ of the ~~more recent compounds produced non-linear dose-~~effect ~~curves~~ and ~~one compound produced an inverted U-shaped dose~~-effect, ~~such that intermediate dose fully substituted~~, but ~~higher~~ doses ~~did not (Gatch and Forster, 2018). All~~ of ~~the compounds identified as~~ available on the ~~recreational market and submitted to our laboratory by the US Drug Enforcement Agency for testing have fully substituted at some dose (Gatch and Forster 2014~~, ~~2015, 2016, 2018); however; it is~~ important ~~to note that not all structural congeners are active (Wiley et al~~.~~, 2012<br>~~<br>~~Figure 1~~. <br>~~Each training session lasted a maximum~~ of ~~10 min,~~ and ~~the rats could earn up to 20 food pellets~~. ~~Thirty minutes prior to the training sessions~~, ~~rats received an injection of either vehicle or Δ9-THC and were subsequently placed~~ in the ~~behavior~~-~~testing chambers, where food (45~~-~~mg food pellets; Bio-Serve~~, ~~Frenchtown, NJ)~~ was ~~available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever~~. ~~A houselight was centered over the hopper close to the ceiling~~ and ~~was illuminated only when the levers were active~~. ~~Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control~~. ~~Twenty~~-~~four male Sprague-Dawley rats were obtained~~ from ~~Envigo (Houston~~, ~~TX)~~. ~~Male ND4 Swiss–Webster mice were obtained from Envigo (Houston~~, ~~TX)~~ at ~~approximately 8 weeks~~ of ~~age~~ and ~~maintained in~~ the ~~University~~ of ~~North Texas Health Science Center (UNTHSC) animal facility for two weeks prior~~ to ~~testin~~<br><br><br>~~LC separates~~ the ~~urine or blood sample~~ and ~~QTOF-MS provides high-resolution and accurate mass measurements~~ for ~~precise identification and structural elucidation~~ of compounds. ~~The LC-QTOF-MS method offers~~ a ~~more comprehensive and sensitive approach for drug detection~~, ~~covering hundreds of recreational drugs~~, ~~including NPS. Besides increasing the temperature to enlarge the drug aerolisation~~ and ~~bioavailability, one can elevate~~ the ~~flow rate~~ of ~~air through~~ the ~~e-cigarette and~~/~~or add a diluent~~ . ~~Of all e~~-~~cigarette users registered at this forum~~, 7.8 ~~% vaped SCRAs . About 15 % of individuals registered at forums for drug users such as erowid.org who vaped cannabis~~ have ~~also vaped SRCAs. SCRAs belong~~, ~~together~~ with ~~synthetic opioids~~, ~~cathinones~~, ~~amphetamines~~ and ~~hallucinogens~~ to ~~the new psychoactive substances (NPS) that are currently developed at high speed.<br>Data availabili~~	+	Figure 1. <br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>The current study indicates that the test compounds produce locomotor depression similar to that of Δ9-THC, and fully substitute for the discriminative stimulus effects of Δ9-THC. In summary, these 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA have similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in a similar fashion. Much of the in vivo [https://cannabinoidsrc4f-adb.com/ navigate here] testing of the synthetic cannabinoid compounds have been pre-clinical studies focused on their cannabinoid-like effects or like the present study, focused on their abuse liability. There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016<br><br><br>Due to the unknown toxicity of newly emerging SCRAs, forensic assessments of cases involving these substances are challenging. According to the reported cases and reviews of the scientific literature, concurrent ethanol consumption should amplify the toxicity of SCRAs. The concentration of 4F-MDMB-BINACA in the postmortem blood was 2.50 and 2.34 ng/mL, and blood alcohol concentration was 2.11 and 2.49 g/L, respectively. Two fatal cases are reported caused by simultaneous consumption of 4F-MDMB-BINACA and ethanol.<br>Fig. 2. <br>The precursor ion m/z 396 (B10, B12/B15) was 32 Da higher than the parent drug, 4F-MDMB-BINACA, suggesting the addition of two hydroxy groups. All the below explanations for transformations into metabolites are based on the data shown in Fig. Metabolites were identified according to their precursor ions, product ions, and fragmentation patterns (Fig. 1). Traditional in-vivo metabolism studies to generate human metabolites of drugs relied heavily on the use of whole animal model systems, which are expensive, limited by drug administration amount, influenced by species variation and faced by many ethical issues. Eight in-vivo metabolites tentatively identified were mainly products of ester hydrolysis with or without additional dehydrogenation, N-dealkylation, monohydroxylation and oxidative defluorination with further oxidation to butanoic acid.<br>Fig. 1. <br>Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, navigate here liver microsomes and confirmed using urine samples The threshold for fatal overdose of combined use of SCRAs and ethanol can be estimated as a little ng/mL (0.37–4.1 ng/mL according to the reported cases) of SCRA and 1.5–2.5 g/L of ethanol. The reported cases and reviews of the scientific literature suggest a possible synergistic effect between SCRAs and ethanol, because their combined use clearly increases their toxicity. The victim died due to severe necrotizing pancreatitis and acute kidney injury evolving into multi-organ failure 11 days after hospital admission . Studies have found no unequivocal synergistic effect between THC and ethanol at low or moderate ethanol doses [29, 30], but no data on high doses of ethanol are available. Given that THC and ethanol act on the same receptors, data on their simultaneous use may yield important insights in this regard.<br>Fungus C. elegans <br>Concentrations of 4F-MDMB-BINACA in the postmortem blood samples were 2.50 and 2.34 ng/mL, which are in line with published data. Although the lethal dose of 4F-MDMB-BINACA is unknown, its concentration in postmortem blood samples was found to range between 0.10 and 2.90 ng/mL . In SCRA-related cases in which the deceased suffered from heart disease, the SCRA concentration in the postmortem blood was less than 1 ng/mL . Concentrations of SCRAs in postmortem cases cover a wide range ; however, some reports of survival have also been published—even at relatively high blood SCRA concentrations [19, 20<br><br> Furthermore, users of these vapes and alerting authorities may not notice the addition of recreational drugs to the e-liquid as the smell of recreational drugs is lost during vaping due to the specific smell of added flavours<br><br><br>Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound

← Nächstältere Version		Version vom 30. Mai 2026, 18:49 Uhr
Zeile 1:		Zeile 1:
−	~~A 30-min period, beginning when maximal depression~~ of locomotor activity ~~first appeared~~ as a function of dose~~, was used for analysis~~ of dose-~~response data~~ and ~~calculation~~ of ~~ED50 values~~. ~~During~~ test ~~sessions~~, ~~both levers were active~~, ~~such that ten consecutive responses on either lever led~~ to [https://cannabinoidsrc4f-adb.com/ ~~5CLADBA~~] ~~reinforcement~~. ~~The substitution tests occurred only if the rats had achieved 85% injection-appropriate responding on the two prior training sessions~~.<br>~~The locomotor activity assay was used to identify approximate time courses and dose ranges of psychoactive effects, which is useful for identifying parameters for drug discrimination experiments~~ and are ~~also predictive of the time course of the psychoactive effects in human users. The purpose of the present study was to assess the abuse liability of 5F-MDMB-PINACA~~, ~~MDMB~~-~~CHIMICA, MDMB~~-~~FUBINACA, ADB-FUBINACA,~~ and ~~AMB-FUBINACA. Since there is currently no robust measure of the reinforcing/rewarding effects of cannabinoids, drug discrimination~~ is ~~currently the best model for assessing abuse liability of cannabinoids~~. ~~The findings produce an apparent paradox, since CPP~~ and ~~self-administration predict with high reliability the likelihood that a compound will~~ be ~~abused~~ by ~~humans~~, ~~and cannabinoids are well~~-~~known~~ to ~~produce active drug~~-~~seeking in human~~<br><br><br>~~Product ions detected at m~~/~~z 302, 217, and 145 (B2) confirmed~~ that ~~tert-leucine and indazole moieties remained unchanged~~, ~~leading to~~ the ~~structure elucidation of a hydroxy~~-~~functional group at~~ the ~~4-position of~~ the ~~butyl side chain by oxidative defluorination. The product ion m/z 336 (loss of methyl ester moiety) further confirmed~~ the ~~presence~~ of ~~dihydroxylated metabolites~~. ~~The precursor ion~~, ~~m/z 364 (B14, B5/B6) had a loss of 2 Da from m/z 366 indicated further dehydrogenation~~ of the ~~ester hydrolysis plus monohydroxylated metabolites~~. ~~The presence of the product ion m/z 320~~, ~~likely formed from a loss of carbon dioxide~~, ~~indicated monohydroxylation at the tert-leucine~~ in ~~B8 (m/z 219)~~, ~~butyl side chain in B9 (m/z 145)~~ and ~~indazole moiety in B13 (m/z 161). The precursor ion, m/z 350 showed~~ a ~~loss~~ of ~~14 Da explaining~~ the ~~hydrolysis~~ of ~~methyl ester from 4F~~-~~MDMB-BINACA~~.<br>~~Fig. 2.~~ <br>~~4F-MDMB-BINACA~~ was ~~hydrolysed via ester hydrolysis forming the 4F~~-~~MDMB-BINACA ester hydrolysis metabolite (B22). Data obtained from the twenty urine samples were retrospectively analysed~~ and ~~processed using TraceFinder software based on the identification criteria~~ of ~~mass errors less than ± 5 ppm for full MS peaks~~ and ~~MS/MS peaks from~~ the ~~theoretical mass and matching of MS/MS spectra~~. ~~The mixture was vortex~~-~~mixed and 500 µL of this mixture and 500 µL of methanol were loaded onto~~ the ~~Clean Screen FASt® tube. After incubation~~, the ~~mixture~~ was ~~cooled at room temperature~~, ~~and 150 µL of purified water was added. High~~-~~resolution QTOF-MS data were acquired on an Agilent 6510 Accurate Mass QTOF mass spectrometer (Agilent Technologies) equipped with dual electrospray ionization (ESI) source operated~~ in ~~both positive and negative ion modes, to determine accurate masses of~~ the ~~metabolites~~. ~~Chromatographic separation was performed on an Agilent 1290 LC system with a Poroshell 120 EC~~-~~C18 analytical column~~ (2.~~7 μm~~, ~~75 × 2~~.~~1 mm; Agilent Technologies~~, ~~Santa Clara~~, ~~CA, USA).<br>Fig. 1. <br>Monitoring metabolism~~ of ~~synthetic cannabinoid 4F~~-~~MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell~~ line, ~~fungus, 5CLADBA liver microsomes and confirmed using urine samples The threshold for fatal overdose of combined use of SCRAs and ethanol can~~ be ~~estimated as a little ng/mL (0.37–4.1 ng/mL according to the reported cases) of SCRA and 1.5–2.5 g/L of ethanol. The reported cases and reviews~~ of the ~~scientific literature suggest a possible synergistic~~ effect ~~between SCRAs~~ and ~~ethanol, because their combined use clearly increases their toxicity. The victim died due to severe necrotizing pancreatitis and acute kidney injury evolving into multi~~-~~organ failure 11 days after hospital admission . Studies have found no unequivocal synergistic~~ effect ~~between THC and ethanol at low or moderate ethanol doses [29~~, ~~30]~~, but ~~no data on high~~ doses of ~~ethanol are~~ available~~. Given that THC~~ and ~~ethanol act on~~ the ~~same receptors~~, ~~data on their simultaneous use may yield~~ important ~~insights in this regard~~.<br>~~Fungus C~~. ~~elegans~~ <br>~~Methyl (2S)~~-2-([1-(4-~~fluorobutyl~~)~~-1H-indazole-3-carbonyl]amino)-3,3-dimethylbutanoate~~ (~~4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4F-ADB~~)~~, found in numerous SCB product seizures, has been reported by various law enforcement since 2018~~ . ~~However, most of~~ the ~~SCBs are full agonists at CB1~~ and ~~CB2 receptors, having a higher risk of undesirable side effects~~ when compared to ~~THC which is a partial agonist~~ . ~~Synthetic cannabinoids~~ (~~SCBs~~) ~~are agonists at cannabinoid receptor type 1~~ (~~CB1~~) and ~~type 2~~ (~~CB2~~)~~, where they elicit their main effect~~<br><br><br>~~Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con~~. ~~All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in~~ a ~~dose-dependent manner~~. ~~A total~~ of ~~5 mice in~~ the ~~JWH~~-~~081 (5 mg~~/~~kg, i.p~~.~~) treated group and 6 mice in the 5CLADBA JWH~~-~~210 (5 mg/kg~~, i.p.~~) treated group showed loss~~ of ~~traction~~, ~~of which 4~~ and ~~5 showed tremor, respectively. Memory retention was measured after~~ the ~~memory acquisition was tested as a probe trial~~.<br>~~About Powder JWH-2~~	+	All of the compounds tested in the present study depressed locomotor activity as is typical for other synthetic cannabinoids (see review by Wiley et al., 2017). Average horizontal activity counts/10 min as a function of time (10 min bins) and dose. Depressant effects of 1.33 mg/kg were observed within 10 min following administration and peak depressant effects were 5CL ADBA powder observed between 0–30 min. Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/k<br><br><br>LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden [https://cannabinoidsrc4f-adb.com/ 5CL ADBA powder] headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly available.<br>Data availability <br>When clinical presentation and/or initial DOA testing results are inconclusive, additional testing with LC-QTOF-MS can be valuable and is recommended. SCRAs and other NPS may not be detected by point-of-care DOA tests. In this case, the point-of-care DOA urine screening was not able to detect the synthetic cannabinoid ADB-BUTINAC<br><br><br>Demographic and clinical features are recorded and blood and/or urine samples analysed using high-resolution accurate mass liquid chromatography-mass spectrometry. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Second, we could not 5CL ADBA powder retrieve further detailed information about the e-cigarette that was used by the patient such as the label or the region of origin. Whether a recreational drug can be administered via vaping, depends on whether the drug becomes volatile under the evaporation temperature of the e-cigarette. Of these samples, 22 contained one or more SCRAs, THC was only detected in 11 samples, only one contained cannabidiol and 6 contained a mixture of THC and cannabidiol. There is difficulty in finding the right information about the NPS, defining their potency and confirmation of their existence in e-liquids or urine samples.<br>Data availabili<br><br><br>Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mice. AMB-FUBINACA has been implicated in severe adverse effects in recreational users (Adams et al., 2017; Hamilton et al., 2017), which suggests that the range between behaviorally active and toxic doses of AMB-FUBINACA is narrow. Following that line of reasoning, it should also be noted that some of the more recent compounds produced non-linear dose-effect curves and one compound produced an inverted U-shaped dose-effect, such that intermediate dose fully substituted, but higher doses did not (Gatch and Forster, 2018). All of the compounds identified as available on the recreational market and submitted to our laboratory by the US Drug Enforcement Agency for testing have fully substituted at some dose (Gatch and Forster 2014, 2015, 2016, 2018); however; it is important to note that not all structural congeners are active (Wiley et al., 2012<br><br>Figure 1. <br>Each training session lasted a maximum of 10 min, and the rats could earn up to 20 food pellets. Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin<br><br><br>LC separates the urine or blood sample and QTOF-MS provides high-resolution and accurate mass measurements for precise identification and structural elucidation of compounds. The LC-QTOF-MS method offers a more comprehensive and sensitive approach for drug detection, covering hundreds of recreational drugs, including NPS. Besides increasing the temperature to enlarge the drug aerolisation and bioavailability, one can elevate the flow rate of air through the e-cigarette and/or add a diluent . Of all e-cigarette users registered at this forum, 7.8 % vaped SCRAs . About 15 % of individuals registered at forums for drug users such as erowid.org who vaped cannabis have also vaped SRCAs. SCRAs belong, together with synthetic opioids, cathinones, amphetamines and hallucinogens to the new psychoactive substances (NPS) that are currently developed at high speed.<br>Data availabili

← Nächstältere Version		Version vom 30. Mai 2026, 18:33 Uhr
Zeile 1:		Zeile 1:
−	~~In the present study~~, ~~we evaluated the neurotoxicity~~ of ~~two synthetic cannabinoids (JWH-081 and JWH-210) through observation~~ of ~~various behavioral changes and~~ analysis of histopathological changes using experimental mice with various doses (0.1, 1, 5 mg/kg<br><br><br>As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-~~cigarette) earlier that day just before the onset~~ of ~~his symptoms~~. ~~Metabolic acidosis (1/3~~, 0/7) and respiratory acidosis (1/3, 0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance detected, while in seven other substances of misuse were ~~also detected including other SCRA~~, opioids, benzodiazepines cocaine and pregabali<br><br><br>Buy Jwh-210 at USA K2 INCENSE STORE and enjoy premium quality, flexible quantities, and fast, secure shipping. Fast shipping and pure product-highly recommended for anyone needing quality incense ingredients." 🌟🌟🌟🌟🌟 You can buy jwh-210 online in quantities of [https://cannabinoidsrc4f-adb.com/ 5CLADBA] 10g, 30g, 50g, 100g, 150g, and 200g at USA K2 INCENSE STORE for premium quality and discreet shipping. In some areas, it is classified as a controlled substance, while in others, it may be legal for research or incense use. The ~~legal status of jwh~~-~~210 varies by country and region~~.<br> ~~Key Features~~ and ~~Specifications~~ to ~~Evaluate <br>In case~~ of ~~cannabis or Δ9~~-~~tetrahydrocannabinol~~, ~~there are many 5CLADBA previous studies regarding with their dependence potential and neurotoxicity (Cororan~~, ~~et al.~~, ~~1974; Harris~~, ~~et al., 1974; Leite~~ and ~~Culini, 1974; Hutcheson, et al~~., ~~1998). After administering test substances once every other day~~ for ~~10 days, brain samples~~ of ~~mice were collected, especially at nucleus accumbens and hippocampus regions~~. ~~Drug was administered 5 times every other day~~, and ~~the first trial was performed 2 h after the last~~ administration~~.<br> How to Choose Powder JWH-210 <br>This dual-use nature underscores~~ the ~~importance of responsible sourcing and strict adherence to legal frameworks. Forensic labs, public health researchers~~, and ~~customs officials use authentic samples like JWH~~-~~210~~ to ~~distinguish between legal and illegal compounds~~ in seized materials. For those seeking a dependable compound for analytical purposes, JWH-210 Chemical Powder provides a trusted and effective solution. With its carefully controlled production process, stable composition, and secure packaging, it remains a valuable resource for laboratory-based researc<br><br><br>~~To evaluate whether~~ the ~~changes~~ of ~~coordinative functions by CNS damages were due to test substances, rota~~-~~rod test was performed using Rota~~-~~rod apparatus~~ (~~Daejong, Seoul, Korea~~). The ~~test apparatus for the locomotor activity test was designed to measure locomotor activity automatically using UV system~~ (~~AM 1051~~, ~~Benwick Electronics, Benwick, UK~~) ~~when experimental animals moved in~~ the ~~chamber~~. ~~In both tests~~, a ~~group~~ of ~~mice were treated with negative control~~ (~~vehicle~~, ~~1 mg~~/~~kg, i.p.~~)~~, positive control~~ (~~methamphetamine, 1 mg~~/~~kg, i~~.~~p.)~~, ~~or one~~ of the ~~three doses~~ of ~~test substances (0~~.~~1, 1, 5 mg/kg, i.p.) once every other day for 10 day<br>~~<br> Fig. 2. <br>~~Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations~~ (~~BAC~~) were ~~2.11~~ and ~~2.49 g~~/~~L, respectively). Forensic autopsy of both victims was performed four days after~~ the ~~time~~ of ~~death following the Recommendation No~~.~~R (99)3 of the Council of Europe on medico~~-~~legal autopsies. Elegans demonstrated the ability to form all~~ of ~~the in-vivo metabolites~~ and ~~has~~ the ~~potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs~~. ~~Thus~~, ~~identification of~~ the ~~relevant urinary markers~~ was ~~based primarily upon the prevalence~~ of ~~the~~ in~~-vivo metabolites instead~~ of the metabolites ~~ranking that~~ was ~~based upon % peak area abundance ratio~~. ~~Moreover~~, ~~genetic makeup~~, ~~physiological conditions (age~~, ~~gender 5CLADBA and ethnicity)~~, ~~environmental influences (diet~~) ~~and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs~~. ~~It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite~~.<br>~~Data concerning the combined effects~~ of ~~SCRAs~~ and ~~other substances are highly limited, which renders forensic evaluation of possible overdose cases difficult .~~ The threshold ~~SCRA concentration~~ for fatal overdose can be estimated ng/mL ~~level~~ (0.37–4.1 ng/mL according to the reported cases) ~~in cases in which~~ 1.5–2.5 g/L of ethanol ~~is present in~~ the ~~blood~~. The ~~victims were brothers who were both~~ found ~~deceased after consuming 4F-MDMB-BINACA~~ and ethanol. ~~These confusing shorter names were not scientifically adopted but were used by websites selling~~ the ~~drugs to the public~~. ~~Monitoring metabolism of synthetic cannabinoid~~ 4F-MDMB-BINACA ~~via high~~-~~resolution mass spectrometry assessed~~ in ~~cultured hepatoma cell line~~, ~~fungus~~, ~~liver microsomes~~ and ~~confirmed using urine samples~~. ~~This article does not contain any studies~~ with ~~human participants or animals performed by any~~ of the ~~author~~	+	A 30-min period, beginning when maximal depression of locomotor activity first appeared as a function of dose, was used for analysis of dose-response data and calculation of ED50 values. During test sessions, both levers were active, such that ten consecutive responses on either lever led to [https://cannabinoidsrc4f-adb.com/ 5CLADBA] reinforcement. The substitution tests occurred only if the rats had achieved 85% injection-appropriate responding on the two prior training sessions.<br>The locomotor activity assay was used to identify approximate time courses and dose ranges of psychoactive effects, which is useful for identifying parameters for drug discrimination experiments and are also predictive of the time course of the psychoactive effects in human users. The purpose of the present study was to assess the abuse liability of 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA. Since there is currently no robust measure of the reinforcing/rewarding effects of cannabinoids, drug discrimination is currently the best model for assessing abuse liability of cannabinoids. The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in human<br><br><br>Product ions detected at m/z 302, 217, and 145 (B2) confirmed that tert-leucine and indazole moieties remained unchanged, leading to the structure elucidation of a hydroxy-functional group at the 4-position of the butyl side chain by oxidative defluorination. The product ion m/z 336 (loss of methyl ester moiety) further confirmed the presence of dihydroxylated metabolites. The precursor ion, m/z 364 (B14, B5/B6) had a loss of 2 Da from m/z 366 indicated further dehydrogenation of the ester hydrolysis plus monohydroxylated metabolites. The presence of the product ion m/z 320, likely formed from a loss of carbon dioxide, indicated monohydroxylation at the tert-leucine in B8 (m/z 219), butyl side chain in B9 (m/z 145) and indazole moiety in B13 (m/z 161). The precursor ion, m/z 350 showed a loss of 14 Da explaining the hydrolysis of methyl ester from 4F-MDMB-BINACA.<br>Fig. 2. <br>4F-MDMB-BINACA was hydrolysed via ester hydrolysis forming the 4F-MDMB-BINACA ester hydrolysis metabolite (B22). Data obtained from the twenty urine samples were retrospectively analysed and processed using TraceFinder software based on the identification criteria of mass errors less than ± 5 ppm for full MS peaks and MS/MS peaks from the theoretical mass and matching of MS/MS spectra. The mixture was vortex-mixed and 500 µL of this mixture and 500 µL of methanol were loaded onto the Clean Screen FASt® tube. After incubation, the mixture was cooled at room temperature, and 150 µL of purified water was added. High-resolution QTOF-MS data were acquired on an Agilent 6510 Accurate Mass QTOF mass spectrometer (Agilent Technologies) equipped with dual electrospray ionization (ESI) source operated in both positive and negative ion modes, to determine accurate masses of the metabolites. Chromatographic separation was performed on an Agilent 1290 LC system with a Poroshell 120 EC-C18 analytical column (2.7 μm, 75 × 2.1 mm; Agilent Technologies, Santa Clara, CA, USA).<br>Fig. 1. <br>Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, 5CLADBA liver microsomes and confirmed using urine samples The threshold for fatal overdose of combined use of SCRAs and ethanol can be estimated as a little ng/mL (0.37–4.1 ng/mL according to the reported cases) of SCRA and 1.5–2.5 g/L of ethanol. The reported cases and reviews of the scientific literature suggest a possible synergistic effect between SCRAs and ethanol, because their combined use clearly increases their toxicity. The victim died due to severe necrotizing pancreatitis and acute kidney injury evolving into multi-organ failure 11 days after hospital admission . Studies have found no unequivocal synergistic effect between THC and ethanol at low or moderate ethanol doses [29, 30], but no data on high doses of ethanol are available. Given that THC and ethanol act on the same receptors, data on their simultaneous use may yield important insights in this regard.<br>Fungus C. elegans <br>Methyl (2S)-2-([1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4F-ADB), found in numerous SCB product seizures, has been reported by various law enforcement since 2018 . However, most of the SCBs are full agonists at CB1 and CB2 receptors, having a higher risk of undesirable side effects when compared to THC which is a partial agonist . Synthetic cannabinoids (SCBs) are agonists at cannabinoid receptor type 1 (CB1) and type 2 (CB2), where they elicit their main effect<br><br><br>Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con. All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in a dose-dependent manner. A total of 5 mice in the JWH-081 (5 mg/kg, i.p.) treated group and 6 mice in the 5CLADBA JWH-210 (5 mg/kg, i.p.) treated group showed loss of traction, of which 4 and 5 showed tremor, respectively. Memory retention was measured after the memory acquisition was tested as a probe trial.<br>About Powder JWH-2

← Nächstältere Version		Version vom 26. Mai 2026, 22:09 Uhr
Zeile 1:		Zeile 1:
−	~~Synthetic cannabinoids have consistently been~~ shown to ~~produce discriminative stimulus effects similar~~ to ~~those [~~https://cannabinoidsrc4f-adb.com/ ~~5CLADBA] of Δ9-THC (Bannister~~ and ~~Connor~~, ~~2018~~), and ~~MDMB~~-~~FUBINACA fully substituted for Δ9-THC~~ (~~Gamage et al.~~, ~~2018~~). The ~~chemical structures~~ of the ~~recent synthetic cannabinoids are unlike that~~ of Δ9-~~THC~~, ~~but~~ are ~~largely based on the structure~~ of ~~older synthetic~~ cannabinoids ~~that~~ are ~~known to~~ have ~~substantial abuse liability~~ (~~Fig~~. 1). All ~~5 compounds decreased locomotor activity and produced~~ discriminative stimulus effects ~~similar to those~~ of Δ9-THC, ~~which suggests they may have abuse liability similar to that~~ of Δ9-~~THC~~. ~~Subsequent testing identified 5F~~-~~ADB to have been present in~~ a ~~total of ten people who had died from unexplained drug overdoses in Japan~~ between ~~September 2014~~ and ~~December 2014~~. ~~AMB~~-~~FUBINACA produced tremors~~ and ~~may be~~ of ~~increased risk in human recreational users~~.<br>Michael B Gatch <br>~~Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/kg.~~ Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the highest dose tested (0.5 mg/kg). ~~Figure 1 shows average horizontal activity counts/10 min as a function of time (0–4 h) and dose of Δ9-TH<br>~~<br>Figure 1. <br>~~Each training session lasted a maximum~~ of ~~10 min, and~~ the ~~rats could earn up to 20 food pellets. Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9~~-~~THC~~ and ~~were subsequently placed in the behavior-testing chambers, where food~~ (~~45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever~~. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX)~~. Male ND4 Swiss–Webster mice were obtained from Envigo (Houston~~, ~~TX) at approximately 8 weeks of age~~ and ~~maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin<br><br><br>LC-QTOF-MS represents~~ a ~~significant advancement in~~ the ~~field of drug detection~~, ~~offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point~~-of-~~care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA~~, ~~a synthetic cannabinoid. We report a 27-year-old man who~~ was ~~admitted~~ to ~~the emergency room because of sudden 5CLADBA headache~~, ~~nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is~~ not commonly availabl<br><br>Figure 1. <br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (~~Fantegrossi~~ et al., ~~2014~~). ~~Discriminative stimulus effects were~~ tested in ~~rats trained to discriminate Δ9-tetrahydrocannabinol~~ (~~3 mg/kg, 30-min pretreatment). 5F-~~MDMB-PINACA ~~(also known as 5F-ADB, 5F-ADB-PINACA)~~, MDMB-~~CHIMICA~~, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA ~~(also known~~ as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>Taken together these data further confirmed the structure elucidation of B16. The precursor ion m/z 276 (B1) detected, which was 74 Da lower than that for the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicated N-dealkylation of B22. The precursor ion m/z 348 and product ion detected at ~~m/z 217~~ (B2) identified was 2 Da less than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicating oxidative defluorination (loss of fluorine with addition of hydroxy 5CLADBA group<br><br><br>Buy Jwh-210 at USA K2 INCENSE STORE and enjoy premium quality, flexible quantities, and fast, secure shipping. Fast shipping and pure product-highly recommended for anyone needing quality incense ingredients." 🌟🌟🌟🌟🌟 You can buy jwh-210 online in quantities of 5CLADBA 10g, 30g, 50g, 100g, 150g, and 200g at USA K2 INCENSE STORE for premium quality and discreet shipping. In some areas, it is classified as a controlled substance, while in others, it may be legal for research or incense use. The legal status of jwh-210 varies by country and region.<br> Key Features and Specifications to Evaluate <br>In case of cannabis or Δ9-tetrahydrocannabinol, there are many 5CLADBA previous studies regarding with their dependence potential and neurotoxicity (Cororan, et al., ~~1974; Harris, et al.~~, ~~1974~~; ~~Leite and Culini, 1974; Hutcheson,~~ et al., ~~1998~~)~~. After administering test substances once every other day for 10 days~~, brain samples of mice were collected, especially at nucleus accumbens and hippocampus regions. Drug was administered 5 times every other day, and the first trial was performed 2 h after the last administration.<br> How to Choose Powder JWH-~~210 <br>This dual~~-~~use nature underscores the importance of responsible sourcing and strict adherence to legal frameworks. Forensic labs, public health researchers, and customs officials use authentic samples~~ like ~~JWH-210 to distinguish between legal and illegal compounds in seized materials. For those seeking a dependable compound for analytical purposes~~, ~~JWH-210 Chemical Powder provides a trusted and effective solution~~. ~~With its carefully controlled production process, stable composition, and secure packaging, it remains a valuable resource for laboratory~~-~~based research.<br> Is JWH-210 Legal? <br>To evaluate whether~~ the ~~changes of coordinative functions by CNS damages were due to test substances~~, ~~rota-rod test was performed using Rota-rod apparatus (Daejong, Seoul, Korea). The test apparatus for~~ the ~~locomotor activity test~~ was ~~designed to measure locomotor activity automatically using UV system (AM 1051, Benwick Electronics, Benwick, UK) when experimental animals moved in the chamber~~. ~~In both tests, a group of mice were treated with negative control (vehicle,~~ 1 mg/kg, ~~i.p.), positive control (methamphetamine, 1 mg/kg, i.p.), or one of~~ the ~~three doses of test substances (0~~.~~1, 1, 5 mg/kg, i.p.) once every other day for 10 day~~	+	Due to the unknown toxicity of newly emerging SCRAs, forensic assessments of cases involving these substances are challenging. According to the reported cases and reviews of the scientific literature, concurrent ethanol consumption should amplify the toxicity of SCRAs. The concentration of 4F-MDMB-BINACA in the postmortem blood was 2.50 and 2.34 ng/mL, and blood alcohol concentration was 2.11 and 2.49 g/L, respectively. Two fatal cases are reported caused by simultaneous consumption of 4F-MDMB-BINACA and ethanol.<br>Fig. 2. <br>The precursor ion m/z 396 (B10, B12/B15) was 32 Da higher than the parent drug, 4F-MDMB-BINACA, suggesting the addition of two hydroxy groups. All the below explanations for transformations into metabolites are based on the data shown in Fig. Metabolites were identified according to their precursor ions, product ions, and fragmentation patterns (Fig. 1). Traditional in-vivo metabolism studies to generate human metabolites of drugs relied heavily on the use of whole animal model systems, which are expensive, limited by drug administration amount, influenced by species variation and faced by many ethical issues. Eight in-vivo metabolites tentatively identified were mainly products of ester hydrolysis with or without additional dehydrogenation, N-dealkylation, monohydroxylation and oxidative defluorination with further oxidation to butanoic acid.<br>Fig. 1. <br>This outcome was anticipated since CES-mediated hydrolysis is commonly https://cannabinoidsrc4f-adb.com/ reported as the major metabolic pathway among the SCBs impacting the terminal ester group . Glucosides and sulfate metabolites have been reported with other SCBs where C. From these three samples, sample 2 contained only an ester hydrolysis metabolite (m/z 350). Both ester hydrolysis followed by oxidative defluorination to butanoic acid (B4, m/z 362) and monohydroxylation at tert-leucine moiety (B8, m/z 366) metabolites were found in 16/20 urine samples (Table 2). A In-vitro metabolites observed in common among respective seven most abundant metabolites in b C. The product ion detected at m/z 235, indicating loss of sulfate, confirmed the identity of the sulfation metabolite.<br>Fungus C. elegans <br>Methyl (2S)-2-([1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4F-ADB), found in numerous SCB product seizures, has been reported by various law enforcement since 2018 . However, most of the SCBs are full agonists at CB1 and CB2 receptors, having a higher risk of undesirable side effects when compared to THC which is a partial agonist . Synthetic cannabinoids (SCBs) are agonists at cannabinoid receptor type 1 (CB1) and type 2 (CB2), where they elicit their main effect<br><br>4. Drugs <br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.<br>Michael B Gatch <br>Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the [https://cannabinoidsrc4f-adb.com/ https://cannabinoidsrc4f-adb.com/] highest dose tested (0.5 mg/kg).<br>Figure 1. <br>There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016). As previously mentioned, all of the compounds tested in the present study (MDMB-PINACA, MDMB-CHMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA) act as agonists at CB1 receptors (Banister et al., 2015, 2016; Gamage et al., 2018), which suggests these compounds will produce Δ9-THC-like effects, including abuse liability. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mice.<br>Michael B Gat